Vice President, Oncology Research

Global Oncology Research

Contribute to building a Global Oncology Research organization by connecting with other sites and integrating a one Oncology mindset in all activities.
As a member of the Global Oncology Research leadership team, develop, and steer the implementation and execution of an Immuno-Oncology strategy that will form the basis of a first-in-class portfolio in line with the overall Discovery Research goals.
Build and maintain a cohesive and productive immuno-oncology organization.
Build and advance a portfolio with novel immunological concepts with first in class potential.
Actively contribute to the portfolio review committees.

Leadership of the RDG Immuno-oncology scientific organization

Ensure scientific and portfolio goals are met.
Strong collaboration across Oncology Research, especially with Oncology Pharmacology and Disease Positioning (OPD in Ridgefield) and across Discovery Research and relevant R&D functions to ensure scientific and portfolio deliverables.

Immuno-Oncology Discovery Activities

Building first-in-class rich innovative portfolio pushing boundaries of current knowledge and utilizes modalities as a "fit for purpose" including small molecules (incl. degraders), biologics, alternative approaches such as viral delivery modalities.
Take trends and emerging clinical learnings actively into consideration for portfolio strategy and NTC discovery.
Levering synergies and collaborating with other units of Oncology Research and other Therapeutic Areas for New Therapeutic Concept (NTC) discovery.
Meet or exceed portfolio deliverables consistent with the Global Oncology and Discovery Research strategies and expectations.
Ensure strong engagement with the local Ridgefield scientific community to maximize synergies. Ensure all relevant documentation is provided to support portfolio deliverables.
Supplement internal NTC discovery with in-licensed compounds as per external innovation strategy for immuno oncology.

External Research Network Establishment

Identify, develop and manage a network of internal and external scientific academic and biotechnology partnerships to discover novel biology and NTC that can be integrated into the Immuno-Oncology portfolio.
Integrate and manage external CRO functions to enable services to be provided for immune oncology.

Internal Network Establishment & Staffing

Build and maintain strong connections with critical functions in Discovery Research (such as modality functions) as well as the Innovation Unit (Experimental Medicine, Computational Innovation, Patents, Business Development) to support effective portfolio building and progression.
In alignment with Global Oncology leadership, develop a strategy to adequately resource Immuno-Oncology portfolio needs leveraging appropriate expertise globally.
Retain and develop high quality staff; performance management of direct and indirect reports strategy.

Operations and Leadership

Ensure compliance with all required training, safety, regulatory, HR, laboratory notebook and intellectual property activities and corporate policies for self and entire Oncology Ridgefield teams.